Merck
MRK
#51
Rank
A$420.22 B
Marketcap
A$170.14
Share price
-0.43%
Change (1 day)
37.52%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): A$5.49

According to Merck's latest financial reports the company's current EPS (TTM) is A$5.08. In 2025 the company made an earnings per share (EPS) of A$10.41 an increase over its 2024 EPS that were of A$9.66.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$5.49-47.3%
2025A$10.417.81%
2024A$9.664308.46%
2023A$0.22-97.32%
2022A$8.1910.92%
2021A$7.3884.68%
2020A$4.00-27.2%
2019A$5.4963.44%
2018A$3.36151.11%
2017A$1.34-54.58%
2016A$2.9430.21%
2015A$2.26-61.99%
2014A$5.95180.51%
2013A$2.12-31.82%
2012A$3.116.62%
2011A$2.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.48 145.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$10.03 97.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.87-63.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.16 1.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$40.33 693.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.69 307.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$3.66-28.05%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$5.09 0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.55 9.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$1.96-61.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel